Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.8 million.

  • Dna X's Consolidated Net Income fell 8921.18% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.0 million, marking a year-over-year decrease of 16253.66%. This contributed to the annual value of -$34.3 million for FY2024, which is 1033701.49% down from last year.
  • Per Dna X's latest filing, its Consolidated Net Income stood at -$4.8 million for Q3 2025, which was down 8921.18% from -$7.5 million recorded in Q2 2025.
  • Over the past 5 years, Dna X's Consolidated Net Income peaked at $527000.0 during Q3 2023, and registered a low of -$22.3 million during Q4 2024.
  • Moreover, its 5-year median value for Consolidated Net Income was -$4.2 million (2022), whereas its average is -$5.2 million.
  • As far as peak fluctuations go, Dna X's Consolidated Net Income soared by 13277.36% in 2023, and later crashed by 229870.69% in 2024.
  • Over the past 5 years, Dna X's Consolidated Net Income (Quarter) stood at -$11.7 million in 2021, then soared by 89.91% to -$1.2 million in 2022, then grew by 21.69% to -$928000.0 in 2023, then tumbled by 2298.71% to -$22.3 million in 2024, then soared by 78.65% to -$4.8 million in 2025.
  • Its last three reported values are -$4.8 million in Q3 2025, -$7.5 million for Q2 2025, and $458000.0 during Q1 2025.